In This Article:
As global markets navigate a landscape marked by geopolitical tensions, fluctuating interest rates, and competitive pressures in the AI sector, investors are keenly observing how these factors influence stock valuations. Amidst this volatility, identifying stocks that may be trading below their estimated value can offer strategic opportunities for those looking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Alltop Technology (TPEX:3526) | NT$264.00 | NT$527.67 | 50% |
| Brookline Bancorp (NasdaqGS:BRKL) | US$12.06 | US$24.01 | 49.8% |
| Sichuan Injet Electric (SZSE:300820) | CN¥50.58 | CN¥101.01 | 49.9% |
| Nordic Waterproofing Holding (OM:NWG) | SEK170.60 | SEK340.70 | 49.9% |
| Elekta (OM:EKTA B) | SEK64.60 | SEK128.36 | 49.7% |
| Kinaxis (TSX:KXS) | CA$171.05 | CA$340.41 | 49.8% |
| AeroEdge (TSE:7409) | ¥1733.00 | ¥3445.33 | 49.7% |
| GemPharmatech (SHSE:688046) | CN¥13.06 | CN¥25.94 | 49.7% |
| QuinStreet (NasdaqGS:QNST) | US$23.71 | US$47.35 | 49.9% |
| Equifax (NYSE:EFX) | US$267.52 | US$531.27 | 49.6% |
Let's uncover some gems from our specialized screener.
Ercros
Overview: Ercros, S.A. is a Spanish company involved in the manufacturing and sale of basic chemicals, intermediate chemicals, and pharmaceuticals, with a market cap of €323.23 million.
Operations: The company's revenue segments include €63.57 million from Pharmaceuticals, €375.76 million from Chlorine Derivatives, and €193.57 million from Intermediate Chemicals.
Estimated Discount To Fair Value: 13.3%
Ercros is trading at €3.55, below its estimated fair value of €4.09, suggesting potential undervaluation based on cash flows. Despite a recent net loss of EUR 7.8 million for the first nine months of 2024, earnings are forecast to grow significantly at 48.52% annually over the next three years, outpacing the Spanish market's growth rate of 8.6%. However, its return on equity remains low and dividend stability is uncertain.
-
The analysis detailed in our Ercros growth report hints at robust future financial performance.
-
Click here to discover the nuances of Ercros with our detailed financial health report.
Vinte Viviendas Integrales. de
Overview: Vinte Viviendas Integrales, S.A.B. de C.V. is a company involved in the development and sale of residential housing in Mexico, with a market cap of MX$9.04 billion.
Operations: The company's revenue primarily comes from its Real Estate Operations & Development segment, generating MX$4.91 billion.
Estimated Discount To Fair Value: 38.7%
Vinte Viviendas Integrales, trading at MX$32.5, is priced below its estimated fair value of MX$53.01, indicating it may be undervalued based on cash flows. Despite past shareholder dilution and insufficient operating cash flow to cover debt, earnings are projected to grow significantly at 23% annually over the next three years, surpassing the Mexican market's growth rate of 11.6%. A recent dividend payout of MX$0.74 reflects ongoing shareholder returns amidst robust earnings forecasts.